Celebrating 20 years
Brain imaging abnormalities and outcome after acute ischaemic stroke: the ENCHANTED trial
Building back better after COVID-19: The research agenda
The wider benefits of SGLT2 inhibitors
New trial has found that treatment with methylprednisolone - a cheap, widely used corticosteroid drug - halves the risk of losing kidney function and kidney failure, and that this can be effectively achieved with fewer side effects if a reduced dose is used.
New research shows that although the ‘classic’ early signs of a stroke such as problems with movement and speech occur in both women and men, women are more likely to have more generalised symptoms, like confusion and weakness.
Salt substitution has been shown to reduce stroke risk by 14 percent and the number of strokes and heart attacks combined by 13 percent, but this new analysis revealed that the costs saved as a result outweighed the cost of the intervention.